Allodynia evoked by intrathecal administration of prostaglandin F2 alpha to conscious mice. 1992

Toshiaki Minami, and Rumiko Uda, and Shigeko Horiguchi, and Seiji Ito, and Masayoshi Hyodo, and Osamu Hayaishi
Department of Anesthesiology, Osaka Medical College, TakatsukiJapan Department of Cell Biology, Osaka Bioscience Institute, SuitaJapan.

The intrathecal administration of prostaglandin F2 alpha to conscious mice resulted in spontaneous agitation and touch-evoked agitation (allodynia) in the animals. The maximum allodynia induced by prostaglandin F2 alpha was observed at 10-15 min after intrathecal injection, and the response did not disappear by 120 min. Prostaglandin F2 alpha produced allodynia over a wide range of dosage from 0.1 pg to 2.5 micrograms/mouse. Dose dependency of prostaglandin F2 alpha for allodynia showed a skewed bell-shaped pattern, and the maximal allodynic effect was observed at 1.0 microgram. This allodynia was dose-dependently relieved by alpha 1-adrenergic (methoxamine), alpha 2-adrenergic (clonidine), and A1-adenosine (RPIA) agonists. Clonidine was 1.5 orders of magnitude more potent than methoxamine in blocking prostaglandin F2 alpha-induced allodynia. The blockade by clonidine was dose-dependently reversed by the alpha 2-adrenergic antagonist yohimbine but not by the alpha 1-adrenergic antagonist prazosin. These results demonstrate that prostaglandin F2 alpha administered intrathecally induces allodynia in conscious mice and that the allodynia involves the alpha 2-adrenergic and A1-adenosine systems. Because this allodynia has a clear resemblance to the characteristics of chronic pain in patients with causalgia and reflex sympathetic dystrophy, prostaglandin F2 alpha may be involved in allodynia observed with these disorders.

UI MeSH Term Description Entries
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D013566 Sympathomimetics Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. Amines, Sympathomimetic,Sympathomimetic,Sympathomimetic Agent,Sympathomimetic Drug,Sympathomimetic Agents,Sympathomimetic Drugs,Sympathomimetic Effect,Sympathomimetic Effects,Agent, Sympathomimetic,Agents, Sympathomimetic,Drug, Sympathomimetic,Drugs, Sympathomimetic,Effect, Sympathomimetic,Effects, Sympathomimetic,Sympathomimetic Amines

Related Publications

Toshiaki Minami, and Rumiko Uda, and Shigeko Horiguchi, and Seiji Ito, and Masayoshi Hyodo, and Osamu Hayaishi
May 1995, Pain,
Toshiaki Minami, and Rumiko Uda, and Shigeko Horiguchi, and Seiji Ito, and Masayoshi Hyodo, and Osamu Hayaishi
February 1990, Brain research,
Toshiaki Minami, and Rumiko Uda, and Shigeko Horiguchi, and Seiji Ito, and Masayoshi Hyodo, and Osamu Hayaishi
March 1986, European journal of pharmacology,
Toshiaki Minami, and Rumiko Uda, and Shigeko Horiguchi, and Seiji Ito, and Masayoshi Hyodo, and Osamu Hayaishi
September 1996, The Journal of pharmacology and experimental therapeutics,
Toshiaki Minami, and Rumiko Uda, and Shigeko Horiguchi, and Seiji Ito, and Masayoshi Hyodo, and Osamu Hayaishi
January 2009, International review of neurobiology,
Toshiaki Minami, and Rumiko Uda, and Shigeko Horiguchi, and Seiji Ito, and Masayoshi Hyodo, and Osamu Hayaishi
October 1997, British journal of pharmacology,
Toshiaki Minami, and Rumiko Uda, and Shigeko Horiguchi, and Seiji Ito, and Masayoshi Hyodo, and Osamu Hayaishi
September 1995, Brain research,
Toshiaki Minami, and Rumiko Uda, and Shigeko Horiguchi, and Seiji Ito, and Masayoshi Hyodo, and Osamu Hayaishi
March 1980, The West Indian medical journal,
Toshiaki Minami, and Rumiko Uda, and Shigeko Horiguchi, and Seiji Ito, and Masayoshi Hyodo, and Osamu Hayaishi
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
Toshiaki Minami, and Rumiko Uda, and Shigeko Horiguchi, and Seiji Ito, and Masayoshi Hyodo, and Osamu Hayaishi
February 1990, Clinical science (London, England : 1979),
Copied contents to your clipboard!